Skip to main content

Table 4 GIA titres at 10 mg/mL IgG in vaccinated and control volunteers

From: Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara

Day

PfAMA1 Malaria Vaccine

Tetanus toxoid vaccine

N

GIA (95 % CI)

N

GIA (95 % CI)

0

20

56 (25–44)

20

59 (19–50)

84

19

68 (7–64)

18

62 (19–53)

365

19

43 (26–31)

17

49 (25–36)